Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ananda Hemp Tincture CBD is a liquid tincture formulation of botanical cannabidiol (CBD) derived from hemp, developed by Ecofibre under the Ananda Hemp brand. It is a full-spectrum hemp extract containing phytocannabinoids, primarily cannabidiol, which acts on the endocannabinoid system as a negative allosteric modulator of cannabinoid receptors CB1 and CB2, as well as an agonist at 5-HT1A and TRPV1 receptors. The drug has been evaluated in clinical trials for sleep disturbances, including a pharmacokinetic study comparing the liquid tincture to a soft gel capsule formulation, and a larger Phase III randomized, placebo-controlled trial conducted in collaboration with Southern Cross University in Australia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ananda Hemp Tincture CBD.